サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1596059

神経血管塞栓装置の世界市場：2033年までの機会と戦略

Neurovascular Embolization Devices Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 313 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.33円
神経血管塞栓装置の世界市場：2033年までの機会と戦略
出版日: 2024年11月21日
発行: The Business Research Company
ページ情報: 英文 313 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の神経血管塞栓装置市場は、2018年に10億6,641万米ドルと評価され、2023年まで3.0％以上の複合年間成長率（CAGR）で成長しました。

神経血管障害に対する認識の高まり

実績期間中、神経血管障害に対する認識の高まりが神経血管塞栓装置市場を牽引してきました。脳卒中や動脈瘤などの疾患の認知度が高まったことで、診断件数が増加し、効果的な治療オプションに対する需要が高まりました。啓発キャンペーンや教育イニシアティブが早期介入の重要性を強調するにつれ、高度な神経血管塞栓装置のニーズが急増しました。このような意識の高まりは潜在的な患者層を拡大し、神経血管疾患の診断と管理のために設計された機器の採用を促進しました。例えば、ワシントン大学シアトル校のInstitute for Health Metrics and Evaluation（IHME）が主導する包括的なイニシアチブであるGlobal Burden of Diseases, Injuries and Risk Factors Study（GBD）によると、2021年には34億人以上（世界人口の40％以上）が神経障害の影響を受けていました。この研究では、37の神経疾患が、世界で4億4,300万人の障害調整生存年（DALY）と1,110万人の死亡の原因となっており、これらの影響の約80％が低・中所得国で発生していることが強調されました。

目次

第1章 エグゼクティブサマリー

  • 神経血管塞栓装置 - 市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 神経血管塞栓装置市場定義とセグメンテーション
  • 市場セグメンテーション：製品別
    • 塞栓コイル
    • 液体塞栓システム
    • 血流転換ステント
    • 動脈瘤クリップ
    • その他の製品
  • 市場セグメンテーション：治療別
    • 虚血性脳卒中の解決策
    • 出血性脳卒中の解決策
  • 市場セグメンテーション：適応症別
    • 脳動脈瘤
    • 動静脈奇形
    • その他の適応症
  • 市場セグメンテーション：エンドユーザー別
    • 病院
    • 外来手術センター
    • その他のエンドユーザー

第7章 主要な市場動向

  • 革新的な薄型可視化腔内サポートデバイスの発売
  • 虚血性脳卒中および出血性脳卒中治療のための新しい神経血管デバイス
  • 複雑な神経血管解剖学のためのカテーテル設計の革新
  • 先進的な塞栓システムにより低侵襲手術が強化された

第8章 神経血管塞栓装置市場 - マクロ経済シナリオ

  • COVID-19の影響：神経血管塞栓装置市場
  • ウクライナ戦争の影響：神経血管塞栓装置市場
  • 高インフレの影響：神経血管塞栓装置市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018年～2023年
    • 市場促進要因、2018年～2023年
    • 市場抑制要因、2018年～2023年
  • 市場成長予測、2023年～2028年、2033年
    • 市場促進要因、2023年～2028年
    • 市場抑制要因、2023年～2028年

第10章 世界の神経血管塞栓装置市場：セグメンテーション

  • 世界の神経血管塞栓装置市場：製品別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の神経血管塞栓装置市場：治療別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の神経血管塞栓装置市場：エンドユーザー別、実績と予測、2018年～2023年、2028年、2033年
  • 世界の神経血管塞栓装置市場：適応症別、実績と予測、2018年～2023年、2028年、2033年

第11章 神経血管塞栓装置市場：地域・国別分析

  • 世界の神経血管塞栓装置市場：地域別、実績と予測, 2018年～2023年、2028年、2033年
  • 世界の神経血管塞栓装置市場：国別、実績と予測, 2018年～2023年、2028年、2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Terumo Corporation
  • Medtronic Inc
  • Penumbra Inc
  • Stryker Corporation
  • Johnson & Johnson

第20章 その他の大手企業と革新的企業

  • Cook Medical LLC
  • Abbott Laboratories
  • MicroPort
  • Asahi Intecc Co Ltd
  • Boston Scientific Corporation
  • Merit Medical Systems, Inc
  • InNeuroCo Inc
  • B. Braun Melsungen AG
  • BALT Group
  • Acandis GmbH
  • Wallaby Medical（Phenox GmbH）
  • Heraeus
  • Integra LifeSciences Corporation
  • Shape Memory Medical
  • NeuroVasc Technologies, Inc

第21章 主要な合併と買収

  • Stryker Corporation Acquired Cerus Endovascular Ltd
  • Boston Scientific Corporation Acquired Obsidio, Inc
  • Wallaby Medical Acquired Phenox GmbH

第22章 機会と戦略

  • 世界の神経血管塞栓装置市場、2028年：新たな機会を提供する国
  • 世界の神経血管塞栓装置市場、2028年：新たな機会を提供するセグメント
  • 世界の神経血管塞栓装置市場、2028年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第23章 神経血管塞栓装置市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第24章 付録

目次
Product Code: o&s1370

neurovascular conditions, particularly those involving abnormal blood flow in the brain. These devices are designed to prevent or reduce blood flow to problematic areas, such as aneurysms, arteriovenous malformations (AVMs) or other vascular abnormalities in the brain. By effectively stopping blood flow to these targeted areas, neurovascular embolization devices help to prevent hemorrhages, reduce bleeding risks and stabilize or resolve potentially life-threatening vascular abnormalities.

The neurovascular embolization devices market consists of sales, by entities (organizations, sole traders and partnerships), of neurovascular embolization devices that are used to treat conditions affecting the blood vessels in the brain.

The global neurovascular embolization devices market was valued at $1,066.41 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 3.0%.

Increasing Awareness Of Neurovascular Disorders

During the historic period, the increasing awareness of neurovascular disorders has driven the neurovascular embolization devices market. The growing recognition of conditions such as stroke and aneurysms led to more diagnoses and a higher demand for effective treatment options. As awareness campaigns and educational initiatives emphasized the importance of early intervention, the need for advanced neurovascular embolization devices surged. This heightened awareness expanded the potential patient population and drove up the adoption of devices designed for the diagnosis and management of neurovascular conditions. For example, in 2021, according to the Global Burden of Diseases, Injuries and Risk Factors Study (GBD), a comprehensive initiative led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Seattle, over 3.4 billion people-more than 40% of the global population-were affected by neurological disorders. The study highlighted that 37 neurological conditions were responsible for 443 million disability-adjusted life-years (DALYs) and 11.1 million deaths globally, with around 80% of these impacts occurring in low- and middle-income countries.

Launch Of Innovative Low-Profile Visualized Intraluminal Support Devices

Major companies operating in the neurovascular embolization devices market are focusing on launching innovative low-profile visualized intraluminal support devices that deliver enhanced imaging clarity during procedures, enabling accurate placement and precise control over deployment. For instance, in June 2024, MicroVention Inc, a US-based company that provides neurovascular embolization devices, announced the launch of its LVIS(TM) EVO(TM) (Low-Profile Visualized Intraluminal Support) Intraluminal Support Device, specifically designed for the treatment of wide-neck intracranial aneurysms in patients aged 18 and above. This stent is distinguished as the first fully visible coil-assist intracranial stent available in the US market, offering enhanced visibility under fluoroscopy, which facilitates accurate placement and controlled deployment. The LVIS(TM) EVO(TM) incorporates advanced design features, including Drawn Filled Tube (DFT) wire construction and an optimized braid angle, enabling improved opening and the capacity to resheath up to 80% of its length.

The global neurovascular embolization devices market is concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 40.6% of the total market in 2023.

Neurovascular Embolization Devices Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global neurovascular embolization devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for neurovascular embolization devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The neurovascular embolization devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider neurovascular embolization devices market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by treatment, by indication and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the neurovascular embolization devices market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by treatment, by indication and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for neurovascular embolization devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
  • 2) By Treatment: Ischemic Stroke Solution; Hemorrhagic Stroke Solutions
  • 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users
  • 4) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
  • Companies Mentioned: Terumo Corporation;Medtronic Plc;Penumbra Inc; Stryker Corporation;Johnson & Johnson
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; neurovascular embolization devices indicators comparison
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Neurovascular Embolization Devices - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Neurovascular Embolization Devices Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Embolization Coils
    • 6.4.2 Liquid Embolic Systems
    • 6.4.3 Flow Diversion Stents
    • 6.4.4 Aneurysm Clips
    • 6.4.5 Other Products
  • 6.5 Market Segmentation By Treatment
    • 6.5.1 Ischemic Stroke Solutions
    • 6.5.2 Hemorrhagic Stroke Solutions
  • 6.6 Market Segmentation By Indication
    • 6.6.1 Brain Aneurysms
    • 6.6.2 Arteriovenous Malformation
    • 6.6.3 Other Indications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Ambulatory Surgical Centers
    • 6.7.3 Other End-Users

7 Major Market Trends

  • 7.1 Launch Of Innovative Low-Profile Visualized Intraluminal Support Devices
  • 7.2 New Neurovascular Devices For Ischemic And Hemorrhagic Stroke Management
  • 7.3 Innovations In Catheter Design For Complex Neurovascular Anatomy
  • 7.4 Advanced Embolic System Enhances Minimally Invasive Procedures

8 Neurovascular Embolization Devices Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Neurovascular Embolization Devices Market
  • 8.2 Impact Of The War In Ukraine On The Neurovascular Embolization Devices Market
  • 8.3 Impact Of High Inflation On The Neurovascular Embolization Devices Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Neurovascular Embolization Devices Market Segmentation

  • 10.1 Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Neurovascular Embolization Devices Market, Regional and Country Analysis

  • 11.1 Global Neurovascular Embolization Devices Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Neurovascular Embolization Devices Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Neurovascular Embolization Devices Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Neurovascular Embolization Devices Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Neurovascular Embolization Devices Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Neurovascular Embolization Devices Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 South America Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Neurovascular Embolization Devices Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Terumo Corporation
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Medtronic Inc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Penumbra Inc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Stryker Corporation
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Johnson & Johnson
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Cook Medical LLC
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Abbott Laboratories
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 MicroPort
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Asahi Intecc Co Ltd
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Boston Scientific Corporation
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Merit Medical Systems, Inc
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 InNeuroCo Inc
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 B. Braun Melsungen AG
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 BALT Group
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Acandis GmbH
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Wallaby Medical (Phenox GmbH)
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Heraeus
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Integra LifeSciences Corporation
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Shape Memory Medical
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 NeuroVasc Technologies, Inc
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Key Mergers And Acquisitions

  • 21.1 Stryker Corporation Acquired Cerus Endovascular Ltd
  • 21.2 Boston Scientific Corporation Acquired Obsidio, Inc
  • 21.3 Wallaby Medical Acquired Phenox GmbH

22 Opportunities And Strategies

  • 22.1 Global Neurovascular Embolization Devices Market In 2028 - Countries Offering Most New Opportunities
  • 22.2 Global Neurovascular Embolization Devices Market In 2028 - Segments Offering Most New Opportunities
  • 22.3 Global Neurovascular Embolization Devices Market In 2028 - Growth Strategies
    • 22.3.1 Market Trend Based Strategies
    • 22.3.2 Competitor Strategies

23 Neurovascular Embolization Devices Market, Conclusions And Recommendations

  • 23.1 Conclusions
  • 23.2 Recommendations
    • 23.2.1 Product
    • 23.2.2 Place
    • 23.2.3 Price
    • 23.2.4 Promotion
    • 23.2.5 People

24 Appendix

  • 24.1 Geographies Covered
  • 24.2 Market Data Sources
  • 24.3 Research Methodology
  • 24.4 Currencies
  • 24.5 The Business Research Company
  • 24.6 Copyright and Disclaimer